COMMUNIQUÉS West-GlobeNewswire

-
Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
14/02/2025 - 22:30 -
Author Andrew Leland Receives 2025 Helen Keller Achievement Award
13/02/2025 - 15:44 -
USOSM Expands Best-in-Class Network of Premier Oral and Maxillofacial Surgeons
13/02/2025 - 15:45 -
Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
13/02/2025 - 16:28 -
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
13/02/2025 - 16:35 -
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
13/02/2025 - 17:00 -
Nutrify Today C-Suite Sumflex 2025 Shaping the Future of Nutraceuticals
13/02/2025 - 17:20 -
Ultimovacs ASA: Cancellation of subsequent repair offering
13/02/2025 - 17:30 -
Merus fera une présentation lors du Citi's 2025 Virtual Oncology Leadership Summit
13/02/2025 - 17:56 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2025
13/02/2025 - 18:00 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025
13/02/2025 - 18:00 -
Over 120 Epilepsy Organizations Applaud the Introduction of the National Plan for Epilepsy Act in Congress
13/02/2025 - 18:45 -
The Shift Towards Proactive Health: Biologic Pharmamedical Stands Firm Amidst Tariffs and Big Pharma Shakeup
13/02/2025 - 18:52 -
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
13/02/2025 - 20:09 -
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
13/02/2025 - 20:09 -
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
13/02/2025 - 21:14 -
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
13/02/2025 - 22:00 -
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
13/02/2025 - 22:01 -
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
13/02/2025 - 22:01
Pages